Orthofix International reported $159.85M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Accuray USD 194.61M 2.03M Sep/2025
AngioDynamics USD 77.97M 10.62M Feb/2025
Artivion USD 85.84M 19.17M Sep/2025
AtriCure USD 81.52M 3.68M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
EDAP TMS EUR 31.4M 2.71M Sep/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Medtronic USD 9.94B 1.6B Sep/2025
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 159.85M 11.47M Sep/2025
Plus Therapeutics USD 10.73M 189K Dec/2023
Smith & Nephew USD 1.54B 236M Dec/2025
STAAR Surgical USD 68.5M 6.87M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Surmodics USD 20.54M 347K Sep/2024
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
Veracyte USD 59.94M 12.22M Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025